chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rash all over the body form the second shot; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received second dose of bnt162b2 (BNT162B2,Solution for injection,Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 2nd dose, single dose for COVID-19 immunization. Patient previously received first dose of bnt162b2 (BNT162B2,Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 1st dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date The patient experienced rash all over the body form the second shot. The outcome of the event rash all over the body was unknown.  Information on the lot/batch number has been requested.
Information has been received from a registered nurse concerning an adult female pt who was vaccinated with a dose of mumps virus vaccine live. The reporter indicated that a doctor told her that the pt died after being vaccinated. The cause of death was not reported. Unspecified medical attention was sought. Additional info has been requested.
This spontaneous report was received from a medical assistant refers to patient of unknown age and gender. On 12-AUG-2014, the patient were vaccinated with GARDASIL (0.5 ml, lot#J011272, expiration date: 21-APR-2016) intramuscularly which underwent a temperature excursion. No adverse events were reported. At the time of the report action taken with GARDASIL was unknown. This is one of several reports from  the same source. Additional information has been requested.
9 days after 1st covid vaccination  I developed red raised itching painful at injection site. 5 days later still with same symptoms
Pt administered vaccine and was only 15 years old.  realized age discrepancy after patient and family already left the vaccination location.  Spoke with Health Department who advised to enter VAERS report and contact guardian of patient.  Health Dept advised that since she received the first dose, to advise pt to second vaccination as well.    Spoke with Mother and Father 1 hr after administration and confirmed pt was asymptomatic.  Reviewed commonly associated side effects of vaccine, acute signs to monitor for, and encouraged pt to follow-up with her primary care provider/ER PRN. Advised pt of health recommendation that an incident report would be submitted but advised pt to receive second vaccine.
JOINT PAIN; This spontaneous report received from a consumer via an unspecified company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported. On an unspecified date, the subject experienced joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of joint pain was not reported. This report was non-serious.
Information has been received from a physician concerning a 22 year old female patient with allergies to codeine (unspecified) and Benadryl and a history of an atypical Papanicolaou smear but negative for human papilloma virus (HPV), who on 04-JAN-2007 was vaccinated, IM, with the first dose of Gardasil and on 08-MAR-2007 was vaccinated, IM, with the second dose of Gardasil. Concomitant therapy included hormonal contraceptives (unspecified). On 08-MAR-2007, the patient's pap smear results were received as "positive for HPV," and the second dose had already been administered. Additional information has been requested.
phone call from mom rash on chest;forearm red rash, tiny pinpoint dots, hot, hivey 45min p/vax;tx observation, DPH;
COVID Vaccine Breakthrough Case   J&J Dose 1 9/8/21 (1808609) COVID Positive 12/6/21  12/6/21: Patient is 23-year-old male with past medical history of congenital hypoplastic kidney status post kidney transplant with rejection, ESRD on hemodialysis at home, secondary hyperparathyroidism, chronic anemia of CKD, pancytopenia, seizure disorder, MRSA bacteremia, endocarditis, chronic hypotension, GERD, PRES, anxiety/depression and ADHD.  Patient was sent to the emergency room from IR room for further evaluation of possible infected hemodialysis access catheter.  Patient was at radiology unit earlier today for IR guided left IJ hemodialysis catheter exchange where he was noted to have purulent discharge around hemodialysis access catheter extends sites.  He was then referred to the emergency room for further evaluation.  Patient has a daily hemodialysis at home with assistance of his family members.  He was at the emergency room 2 days ago for evaluation of failed hemodialysis catheter after he noted failure to draw blood from dialysis access catheter.  Other was patient denied any fever chills or rigors.  No nausea vomiting or abdominal pain.  His last hemodialysis was last Friday 12/03/2021.  Patient has right thigh fistula which is nonfunctional.  Upon evaluation at the emergency room, patient was noted to be hypotensive with systolic blood pressure in the 80s which is close to his baseline.  Patient has chronic hypotension likely due to adrenal insufficiency.  Was tachycardic but maintaining saturation on room air.  He is not febrile.  Lab work is significant for creatinine of 17.5.  At the emergency room, patient received empiric antibiotic vancomycin and Zosyn after culture from peripheral and dialysis access port was obtained.  12/16/21: Blood cultures collected 12/11/2021 reveals no growth to date.  Patient to be discharged on IV daptomycin q.48h, for VNA services at discharge.  For outpatient TEE for evaluation of MRSA bacteremia.  Outpatient follow-up with Infectious Disease specialist  Continue home hemodialysis.  Follow-up with nephrologist. Patient is on room air, no symptoms of COVID-19 infection, continue contact and droplet isolation.  Continue vitamin-C and zinc.  Continue home medications.
Information had been received on 10-MAY-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient (age unknown) was inoculated with ZOSTAVAX on or about 29-SEP-2009 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles (dosage and lot#/expiration not reported). The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 02-JUL-2016, patient was treated by a physician assistant for a painful rash that was diagnosed as shingles. Patient had been prescribed acyclovir to manage her symptoms and outbreaks. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
CLIENT STATED SHE AWOKE ON 7/11/17 WITH HIVE TO THE ANTICUBITAL AREA OF LEFT ARM. CLIENT STATED SHE NOTED MORE HIVES ON 7/12/17. CLIENT STATED SHE IS GOING TO HER PRIMARY.
Apnea Admitted to ICU with V-tach, hospital stated it was vaccine related
Patient was in the office for the wellness visit. was receiving routine 2 year vaccination of Hep A and provider discussed needing Moderna bivalent booster. Registry on the side of the chart, overlooked for notification of moderna bivalent received outside of practice. Moderna bivalent booster received in office. Post vaccination and appointment mom called to notify patient had already received. Patient was in the office with dad at time of appointment, dad completed covid questionnaire and signed consent form
1) patient should not have received Moderna COVID 19 vaccine based on his age. He should have received Pfizer COVID 19 vaccine.  2) he developed sore arm the following day. This resolved within 24 hours.
Pt did not experience redness but the soreness has persisted for several months. She says at times it is difficult to raise her arm. I asked her if she could raise her arm now and she could easily raise it. However, she says that she still experiences soreness and sometimes it is hard to raise her arm.
paralysis of lower extremities witnessed by mother and unresponsive lasted about 4 minutes total. mother took him to emergency room, but by the time she arrived he was well and back to normal self. active and playful
I had tested positive with covid in the ending of December after the holidays. With that I lost my sense of taste and smell. Fast foward, on Monday Feb. 22nd I received the second dose to the covid vaccine, on Friday I was eating tacos and I got this taste in my mouth and my stomach was bothering me I believe from the tacos beings bad (2 other people got sick too) but the taste lingers, The next morning I cook breakfast and lunch and I can smell this smell that I taste as well. It is not March 4th, 1 day shy of it being a week and I am still experiencing this. I can not taste any food flavor except this taste that I have, it has replaced all food flavors and smells. Whenever I cook something I can smell the scent I taste (only when Its food or Im cooking, I can smell my coconut lotion and body spray just fine). I do not know how to describe it I started describing it as it being an old grease taste but it could be a metallic taste I am not sure, all I know it is a very unpleasant taste. Whenever I brush my teeth, immediately when I put the toothpaste in my mouth i immediately taste the taste again its like it almost heightens it. The taste lingers in my mouth after that as well. I do have to say that I tried a chocolate covered pretzels and m&m's and notices that I can taste sweet stuff but immediately get the taste when I eat regular foods thats are not sweet. I tried to eat waffles one time and the syrup taste was fine but I could not eat sausage because of the taste. This is very frustrating because its disgusting that I would rather not taste anything at all. I am unsure if my taste was ever fully back after having covid I was able to start tasting things but not sure if it was 100% as well as I could smell somethings but  not sure if that was 100%. I talked to some people who thought maybe it is my senses trying to fully come back because they heard about people experiencing weird smells when their senses were coming back but I am unsure I just want to not deal with this anymore. I think its weird it came 3 days after the vaccine and that I can not taste food other than this taste.
Redness reappeared 8 days later; itchiness reappeared 8 days later; Swollen glands on left side of body; Redness on arm; bad headache; Stiff neck; Constipation; hasnt felt herself; itchiness on arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen glands on left side of body), VACCINATION SITE ERYTHEMA (Redness on arm), ERYTHEMA (Redness reappeared 8 days later), HEADACHE (bad headache) and MUSCULOSKELETAL STIFFNESS (Stiff neck) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   No medical history provided by reporter.  Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for COVID-19 vaccination.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen glands on left side of body), VACCINATION SITE ERYTHEMA (Redness on arm), HEADACHE (bad headache), MUSCULOSKELETAL STIFFNESS (Stiff neck), CONSTIPATION (Constipation), FEELING ABNORMAL (hasnt felt herself) and VACCINATION SITE PRURITUS (itchiness on arm). On 26-Mar-2021, the patient experienced ERYTHEMA (Redness reappeared 8 days later) and PRURITUS (itchiness reappeared 8 days later). At the time of the report, LYMPHADENOPATHY (Swollen glands on left side of body), VACCINATION SITE ERYTHEMA (Redness on arm), ERYTHEMA (Redness reappeared 8 days later), HEADACHE (bad headache), MUSCULOSKELETAL STIFFNESS (Stiff neck), CONSTIPATION (Constipation), FEELING ABNORMAL (hasnt felt herself), VACCINATION SITE PRURITUS (itchiness on arm) and PRURITUS (itchiness reappeared 8 days later) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
Patient experienced immediate vasovagal response s/p vaccination. Pt maintained consciousness and  was evaluated by EMT . Pts vital signs stabilized without medical intervention. After approximately 15 minutes pts reported feeling much better and declined hospital transportation. Pt will follow up as with PCP .
Constant Itching; Burning sensation under skin; Strange bumps begun to appear (especially on face); Arms have a slight rash; Fingers, wrist, and ankles intermittently hurt (sometimes); Fingers, wrist, and ankles intermittently hurt (sometimes); This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 25Mar2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation, epilepsy, and COVID-19. The patient had an allergy to fish and bananas. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included oxcarbazepine (TRILEPTAL), sotalol (MANUFACTURER UNKNOWN), topiramate (MANUFACTURER UNKNOWN), "hydrochlo" (MANUFACTURER UNKNOWN), and apixaban (ELIQUIS); all for an unknown indication from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The patient previously received phenytoin (MANUFACTURER UNKNOWN) and metoprolol (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 07Apr2021, the patient experienced constant itching and a burning sensation under the skin. On the same day, strange bumps began to appear (especially on the face), arms had a slight rash, and fingers, wrist, and ankles were intermittently (sometimes) hurt. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events constant itching, burning sensation under skin, strange bumps begun to appear (especially on face), arms have a slight rash, and fingers, wrist, and ankles intermittently hurt (sometimes) were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Two small seed size lumps in what appears to be my L posterior external juggular vein and soreness in my L lymph node near the superior armpit.
Patient's caregiver stated that when patient removed bandage the evening of the shot, that clear liquid ran down her arm.
Injection site started itching a week after injection, and still itches and is plainly visible as a raised red bump. My arm below the muscle where shot was given is sore to the touch at the bone. like a bone bruise.
This is a spontaneous report from a contactable consumer (patient's parent). A 23-month-old male patient received PREVNAR 13, via an unspecified route of administration in the thigh, on 02May2017 afternoon, at single dose, for immunisation. Medical history included deaf, pectus excavatum, cochlear function disorder, cortical dysplasia and latent tuberculosis. There were no concomitant medications. The patient had cochlea implant surgery on 04May2017. The patient experienced fever of 102 F on 06May2017 with outcome of recovering, UTI (urinary tract infection) on an unspecified date with outcome of not recovered, leg of vaccination site became really red and a swollen lump like a small egg on 02May2017 with outcome of recovered between 04May2017 and 09May2017 and dehydration on 07May2017 with outcome of unknown. The patient was hospitalized due to fever of 102 F from 07May2017 to 08May2017. The patient underwent lab tests and procedures which included body temperature: 102 F (Fahrenheit) on 06May2017, 103.5 F on 07May2017, 101.5 F on 07May2017, 99 F on 08May2017. Therapeutic measures were taken as a result of fever of 102 F and included treatment with TYLENOL. Clinical course: on 07May2017 they had to go to the doctor because the patient was leaking spinal fluid. The same day the patient had a second surgery because there was a complication with the seal and they had to go back in and reseal it. When he came out of surgery he had a fever of 103.5 F but they believed it was due to dehydration and UTI that was brewing. They brought the fever down but he was admitted to the hospital on 07May2017 and late that evening his fever was back up to 101.5 F. On 08May2017 his temperature reached only 99 F and in the evening the patient was released from the hospital. The reporter thought that maybe UTI was due to the anesthesia from the first surgery because heard that it could cause this because of urine retention, patient's doctor felt like the UTI was brewing before the first surgery.
(L) upper arm redness, swelling and pain 5 days after HPV #1 shot. Clinical diagnosis cellulitis.
Woke during noc with headache and dizziness, sweaty and nauseous she then told mother she felt as if she would faint, then passed out. Regained consciousness in few seconds, complained of achiness had fever 100. deg. Felt fine prior to vaccine went to ER. and discharged home
Right upper arm 1 in x 1 annular area of warmth/redness. Motrin and cool compresses
Information has been received from a physician concerning a currently 24 year old male patient with rhinitis allergic and not known drug reactions or allergies who on 19-MAR-2010, was vaccinated IM with a dose of PNEUMOVAX 23 (Lot # 665402/1339Y). There was no concomitant medication. According to the physician, the patient developed an urticarial reaction at the injection site that lasted for 4 days. At the time of the report the patient had recovered. The patient sought medical attention by an office visit. No diagnostic tests were performed. Follow up information has been received from a physician who indicated that the patient was a male student with pollen, cat, dust mite allergies and rhinitis allergic who on 19-MAR-2010, was vaccinated with a dose of PNEUMOVAX 23 (Lot # 665402/1339Y) into his left deltoid. Concomitant vaccinations included a dose of ADACEL given into his right deltoid. There were no illnesses reported at the time of vaccination. On 19-MAR-2010 the patient experienced hives at the injection site (Left deltoid) that lasted 4 days. On 23-MAR-2010 the patient recovered from hives at the injection site without intervention. Additional information is not expected.
two days later and it was 90 degrees/She checked her temperature and it was 90 degree; throwing up; dizziness; weakness; tightening of her chest and was breathing shallow; woke her up out of a dead sleep; felt really terrible / Had a bad reaction to the first dose of the vaccine; tightening of her chest and was breathing shallow; This is a spontaneous report from a contactable consumer (patient) from Pfizer. A female patient of age 49 (units: unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 11Mar2021 (at the age of 49 (units: unknown)) as single dose for COVID-19 immunization. Medical history included motion sickness. The patient's concomitant medications were not reported. The patient reported that she received the first dose of the pfizer covid 19 vaccine on 11Mar2021. One hour after the shot she started throwing up and she checked her temperature at night and it was 90 degree. She threw up for three to four days. Patient stated that she gets motion sickness. She had dizziness and weakness. Two days later, she took her temperature again and it was 90 degrees. She had tightening of her chest and was breathing shallow and it woke her up out of a dead sleep. She felt really terrible. The patient wanted to know if this had been reported and whether or not it would be safe for her to get other dose because she had the side effects. Outcome of the event throwing up was recovered in Mar2021; other events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt. had a macular papular rash that is on face, torso, bilateral arms, back and going down both legs. Reports a low grade fever the day before.
Patient became bradycardic, hypotensive, pale and diaphoretic. AOx4, GCS 15. Able to speak but slow in response.
Starting on Saturday the 4th through Wednesday the 8th ( it gradually went away between Tuesday and Wednesday ) I had numbness and tingling sensation in my face.  Similar to how you feel when novocaine is wearing off and almost gone.
Itchy hives on torso and under arms.  Condition has persisted since two days post injection  OTC Benadryl Allergy relieves the issue if maintained at regular 4-6 hour intervals.    Similar event occurred with first dose of Moderna.  For the first event, Benadryl was taken for 3 days at 5 hour intervals (1 pill), then moved to 6 hour intervals for 1 day and 7 hour intervals for an additional day.   No reoccurrence of the event until the second dose of Moderna.
Following the first shot I was very sick (fever, cough, runny nose, sore throat, lethargic, coughing) took a covid test and tested negative.  After the second shot, developed itching at the shot site within 2 hours. Woke up the next morning sore and with a runny nose. 20 hours after receiving the shot I have a stiff neck, all over body aches, redness and swelling 3? in diameter at the injection site that did not improve with heat or ice, temperature of 101 degrees that did not improve with tylenol. Shaking, cold and hot flashes, pain in arm and armpit, unable to lift arm  well.
Fatigue; joint in knuckles are aching; headache; sinus pressure; This is a spontaneous report from a contactable consumer(patient). The consumer reported that, a 54-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot Number: EW0176 and expiry date was not reported), via an unspecified route of administration, administered in Arm Right on 26Apr2021(age at vaccination 54- years-old) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history include Known allergies to Penicillin and concomitant medication were not reported. On 01 Jun2021, patient experienced Fatigue, joint in knuckles are aching, headache, sinus pressure. For the treatment he received Advil and Benadryl. Patient has not any other vaccine in four weeks and no other medications in two weeks. The patient stated that he had not been diagnosed with COVID -19 prior to vaccination and since the vaccination, the patient been tested for COVID-19. The patient underwent lab tests and procedures which included sars-cov-2 test (Nasal Swab/ Rapid Test): negative on 02Aug2021. Outcome of the events was not recovered.  Follow-Up (01Sep2021): Follow-up attempts are completed. No further information is expected.